Results 1 to 10 of about 2,260 (197)

Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). [PDF]

PLoS Medicine, 2017
BackgroundExcessive haemorrhage at cesarean section requires donor (allogeneic) blood transfusion. Cell salvage may reduce this requirement.Methods and findingsWe conducted a pragmatic randomised controlled trial (at 26 obstetric units; participants ...
Khalid S Khan, Philip A S Moore, Matthew J Wilson, Richard Hooper, Shubha Allard, Ian Wrench, Lee Beresford, Tracy E Roberts, Carol McLoughlin, James Geoghegan, Jane P Daniels, Sue Catling, Vicki A Clark, Paul Ayuk, Stephen Robson, Fang Gao-Smith, Matthew Hogg, Doris Lanz, Julie Dodds, SALVO study group   +19 more
doaj   +7 more sources

Severe fetomaternal transfusion due to an unrecognized chorangioma in a dichorionic, diamniotic twin pregnancy [PDF]

Archives of Gynecology and Obstetrics
Objectives/hypothesis Severe fetomaternal transfusion due to an unrecognized chorangioma in a dichorionic, diamniotic twin pregnancy: case report and review of the literature. Study design Case report and retrospective narrative review.
Jonas Bubmann, Christian Dannecker, Manuela Franitza, Marina Seefried, Philipp Voisard, Udo Jeschke, Carl Mathis Wild, Fabian Garrido, Tina Schaller, Bernadette Eser   +9 more
doaj   +2 more sources

Severe Hemolytic Disease of the Fetus Treated with Serial Intrauterine Transfusions: A Case Report and Review of Current Management [PDF]

Life
Hemolytic disease of the fetus and newborn (HDFN) is a severe complication of pregnancy caused by maternal alloimmunization to fetal red blood cells, leading to significant perinatal morbidity and mortality.
Olga Olejniczak, Jakub Kornacki, Ewa Wender-Ożegowska   +2 more
doaj   +2 more sources

A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial [PDF]

Health Technology Assessment, 2018
Background: Caesarean section is associated with blood loss and maternal morbidity. Excessive blood loss requires transfusion of donor (allogeneic) blood, which is a finite resource. Cell salvage returns blood lost during surgery to the mother.
Khalid S Khan, Philip Moore, Matthew Wilson, Richard Hooper, Shubha Allard, Ian Wrench, Tracy Roberts, Carol McLoughlin, Lee Beresford, James Geoghegan, Jane Daniels, Sue Catling, Vicki A Clark, Paul Ayuk, Stephen Robson, Fang Gao-Smith, Matthew Hogg, Louise Jackson, Doris Lanz, Julie Dodds   +19 more
doaj   +4 more sources

Fetomaternal Transfusion as a Cause Of Severe Fetal Anemia Causing Early Neonatal Death: A Case Report [PDF]

Oman Medical Journal, 2011
Fetomaternal hemorrhage refers to the entry of fetal blood into the maternal circulation before or during delivery. Very small amount of fetal red cells are normally detectable in all pregnancies. Massive fetomaternal bleed is very rare and even rarer is
Mohammad Abdullatif, Mohammad Abdullatif, Masood Ahmed, Masood Ahmed   +3 more
doaj   +2 more sources

Cerebral injury and long-term neurodevelopment impairment in children following severe fetomaternal transfusion: a retrospective cohort study. [PDF]

Arch Dis Child Fetal Neonatal Ed
Objective: Fetomaternal transfusion (FMT) is associated with increased perinatal mortality and morbidity, but data on postnatal outcomes are scarce. Our aim was to determine the incidence of adverse short-term and long-term sequelae of severe FMT. Design:
El Emrani S, van der Hoorn ML, Tan RNGB, Steggerda SJ, de Vries LS, Haak MC, van Klink JMM, de Haas M, van der Meeren LE, Lopriore E.   +9 more
europepmc   +4 more sources

Emergence of additional anti-C with amplification of anti-D titer post-Rh-Kell phenotype-matched intrauterine transfusions in severe hemolytic disease of fetus [PDF]

Asian Journal of Transfusion Science
Transplacental ultrasound-guided intrauterine transfusion (IUT) acts as a lifesaving therapy to prevent fetal anemia or even to reverse fetal hydrops.
Suhasini Sil, Daljit Kaur, Latika Chawla, Dixa Kumari, Madhulika Singh, Vaidehi Prasanth, Ashish Jain, Gita Negi   +7 more
doaj   +2 more sources

Clinical characteristics and outcomes of pregnancies at-risk of hemolytic disease of the fetus and newborn in Sweden, Finland, and Denmark: a population-based register studyAJOG Global Reports at a Glance [PDF]

AJOG Global Reports
Background: Red blood cell (RBC) alloimmunization is an immune response where the maternal immune system produces antibodies against fetal RBCs, which can lead to hemolytic disease of the fetus and newborn (HDFN).
Kelvin H.M. Kwok, PhD, Mika Gissler, PhD, Mette Ø. Thunbo, MD, PhD, Elizabeth C. Hsia, MD, MSCE, May Lee Tjoa, PhD, Shengxin Liu, PhD, Malin Almgren, PhD, Vedran Stefanovic, MD, PhD, Lars H. Pedersen, MD, PhD, Agneta Wikman, MD, PhD   +9 more
doaj   +2 more sources

Acute Fetomaternal Hemorrhage Confirmed by Maternal Alfa-Fetoprotein in Monochorionic Diamniotic Neonates under 1,500 g [PDF]

Neonatal Medicine, 2020
Fetomaternal hemorrhage (FMH) is due to the entry of fetal blood into the maternal circulation. Although very rare, FMH complicates pregnancies, presents with severe symptoms, and leads to fetal death.
Chaeri Yoo, Sol Han, Hyemi Jeong, Ju Sun Heo, Hyun-Seung Lee, Jihyun Jeon   +5 more
doaj   +1 more source

Spontaneous massive fetomaternal hemorrhage: two case reports and a literature review of placental pathology

BMC Pregnancy and Childbirth, 2023
Background Massive fetomaternal hemorrhage (FMH) is a rare event during pregnancy that may cause severe fetal anemia or death. Case presentation This paper reports two cases of fetomaternal hemorrhage with unexplained reasons.
Yushuang Zheng, Donglu Li, Xinran Li, Aman Zheng, Fan Wang   +4 more
doaj   +1 more source